Building viral vector capacity and capabilities to realize the promise of gene therapies

Watch this on-demand recording of Chris Murphy, Vice President and General Manager, Viral Vector Services at Thermo Fisher Scientific, as he discusses the challenges and opportunities of bringing viral vector products to market and how Thermo Fisher is building capacity and capabilities to realize the promise of gene therapies.

Related Sites

Additional Resources